Profound Medical Corp.
TSX:PRN.TOMedical - Devices
+$0.11 today
- Market cap
- $360.04M
- Beta
- 0.52
- P/E (TTM)
- -6.3
- EPS (TTM)
- -$1.07
Volume 0.00M
Average 0.01M
PRN.TO Other Current Liabilities
Short-term obligations not reported separately, such as accrued expenses.
Profound Medical Corp.TSX: PRN.TO
Other Current Liabilities · Q1 FY2026 · quarter ended Mar 2026
Other current liabilities falls 29.5% from a year ago
Other current liabilities stood at $1.69M at the end of Q1 FY2026, down 29.5% from a year earlier and up 28.9% from the prior quarter. Over 3 fiscal years it compounded at +28.7% a year.
Context
- Other current liabilities amounted to 2.3% of total assets at the end of Q1 FY2026, down 1.6 pp from a year earlier.
- Other current liabilities increased in 2 of the last 3 fiscal years.
What to watch
Whether other current liabilities keeps falling in the next quarterly balance sheet after a -29.5% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Other Current Liabilities history
USD · from the balance sheet
- Latest · FY2025
- 1.31M USD
- Year-over-year change
- +27.1%
- 4-year CAGR
- +680.9%
| Period | Period end | Other Current Liabilities | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 1.31M | +27.1% |
| FY2024 | 2024-12-31 | 1.03M | -27.1% |
| FY2023 | 2023-12-31 | 1.42M | +130.4% |
| FY2022 | 2022-12-31 | 614.09K | +174229.8% |
| FY2021 | 2021-12-31 | 352 | — |
Other Current Liabilities vs competitors
How PRN.TO compares with its peers on the latest reported figures
- Peers report in different currencies, so other current liabilities is compared through growth and share of total assets rather than absolute size.
- Its year-over-year change of -29.5% is the 5th highest of 6, against a peer median of +51.1%.
- Other current liabilities amounts to 2.3% of total assets for PRN.TO, versus a peer median of 2.6%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $15.57M USD | +4.4% | +14.0% | 5.6% | |
| Mar 2026 | $13.71M USD | +51.1% | +20.1% | 10.5% | |
| Mar 2026 | CA$6.48M CAD | +362.7% | -12.3% | 2.6% | |
PRN.TOProfound Medical Corp. | Mar 2026 | $1.69M USD | -29.5% | +28.7% | 2.3% |
| Mar 2026 | $246.6K USD | +564.6% | -2.7% | 0.2% | |
| Mar 2026 | CA$0 CAD | -100.0% | — | 0.0% | |
| Peer median (excluding PRN.TO) | — | +51.1% | +5.6% | 2.6% | |
Competitors are the stored peer set for PRN.TO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 67.15M | 46.52M | 26.21M | 54.91M | 59.61M |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 |
| Net Receivables | 1.4M | 5.89M | 7.29M | 7.05M | 5.24M |
| Inventory | 7.35M | 8.01M | 6.99M | 5.8M | 8.22M |
| Other Current Assets | 0 | 511.6K | 0 | 0 | 2.19M |
| Total Current Assets | 76.48M | 62.59M | 41.9M | 69.07M | 75.95M |
| Property, Plant & Equipment (Net) | 1.9M | 1.72M | 1.53M | 821.01K | 880.39K |
| Goodwill | 2.69M | 0 | 0 | 0 | 0 |
| Intangible Assets | 1.44M | 680K | 490K | 261K | 137.75K |
| Long-term Investments | 4.58M | 0 | 0 | 0 | 299.45K |
| Tax Assets | (4.58M) | 0 | 0 | 87K | 63.35M |
| Other Non-current Assets | 3.62M | 0 | 0 | 0 | 3 |
| Total Non-current Assets | 9.65M | 2.4M | 2.02M | 1.17M | 64.67M |
| Total Assets | 86.78M | 64.42M | 43.91M | 70.23M | 140.62M |
| Account Payables | 3.18M | 2.03M | 865K | 1.32M | 1.56M |
| Short-term Debt | 247.65K | 527.74K | 2.1M | 1.74M | 212.61K |
| Tax Payables | 0 | 298K | 0 | 0 | 0 |
| Deferred Revenue | 477K | 471K | 721K | 419K | 444.19K |
| Other Current Liabilities | 352 | 614.09K | 1.42M | 1.03M | 1.31M |
| Total Current Liabilities | 4.16M | 4.19M | 6.37M | 6.57M | 6.06M |
| Long-term Debt | 0 | 6.71M | 5M | 2.92M | 4.49M |
| Deferred Tax Liabilities | 0 | 0 | 59K | 0 | 63.28M |
| Deferred Revenue (Non-current) | 875K | 764K | 728K | 49K | 387.29K |
| Other Non-current Liabilities | 867.72K | 770.92K | 74K | 71K | 78.86K |
| Total Non-current Liabilities | 1.99M | 8.31M | 6.37M | 3.25M | 68.24M |
| Total Liabilities | 6.16M | 12.42M | 12.73M | 9.81M | 74.3M |
| Common Stock | 217.75M | 207.69M | 217.39M | 281.55M | 323.25M |
| Retained Earnings | (159.36M) | (191.08M) | (217.93M) | (245.17M) | (287.22M) |
| Accumulated OCI | 4.71M | 16.99M | 12.03M | 2.74M | 5.02M |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 80.62M | 52M | 31.18M | 60.42M | 66.31M |
| Total Debt | 1.38M | 8.3M | 7.87M | 5.12M | 4.7M |
| Net Debt | (65.78M) | (38.29M) | (18.35M) | (49.79M) | (54.91M) |
Profound Medical Corp.
TSX:PRN.TO
Intrinsic Alpha fair value
Locked
Current Price
$9.83
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.